Supply chain 2.0: Solving the Molybdenum-99 crisis in 2026
The historical fragility of the medical isotope supply chain has finally been addressed in 2026 through the commissioning of four new LEU production facilities. This diversification has insulated the market from the periodic shortages that once threatened patient care. The global shift toward regional self-sufficiency is a primary driver for the India radiopharmaceutical market size, as...
0 Comments 0 Shares 33 Views 0 Reviews
MakeMyFriends https://makemyfriends.com